AETNA_(UK)_LIMITED - Accounts


Company registration number 02522111 (England and Wales)
AETNA (UK) LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
AETNA (UK) LIMITED
COMPANY INFORMATION
Directors
Mr S Pascucci
Mr M Dicken
Company number
02522111
Registered office
Packaging Heights
Highfield Parc Highfield Road
Oakley
Bedfordshire
MK43 7TA
Auditor
RDP Newmans LLP
Lynwood House
373-375 Station Road
Harrow
Middlesex
HA1 2AW
Business address
Packaging Heights
Highfield Parc Highfield Road
Oakley
Bedfordshire
MK43 7TA
AETNA (UK) LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Statement of cash flows
10
Notes to the financial statements
11 - 21
AETNA (UK) LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 1 -

On behalf of the board

Fair review of the business

The results for the year and financial position of the company are as shown in the annexed financial statements.

 

The Key Performance Indicators of Aetna (UK) Limited over the last two years are detailed below:

 

     2022      2021

Turnover (GBP £'000)            14,538        15,424

Gross profit %                 34.81         33.17

Net profit %                 4.26         4.89

 

The directors recognise the above Key Performance Indicators represent the current economic climate and they are confident they have the policies and procedures in place to ensure that the results in the forthcoming year are maintained should the economic climate remain similar.

Principal risks and uncertainties

The principal risks and uncertainties facing Aetna (UK) Limited are exchange rate risk, credit risk, liquidity risk, market risk, Russia and Ukraine conflict risk and Brexit risk. The board reviews and agrees policies for managing each of these risks and they are summarised below.

 

Exchange rate risk: The company has some exposure to exchange rate fluctuations due to purchasing of goods in foreign currencies, however the majority of the company's purchases are from the parent company who invoice the company in pounds sterling.

 

Credit risk: The company's principal financial assets are bank and cash balances and trade and other receivables. The company’s credit risk is attributable to its trade receivables. The amounts presented in the balance sheet are net of allowances for doubtful receivables. The company has no significant concentration of credit risk, with exposure spread over a large number of counterparties and customers. Appropriate trade terms are negotiated with suppliers and customers and management reviews these terms and their relationship with suppliers and customers and manages any exposure on normal trade terms.

Liquidity risk: The directors consider the company’s banking facilities are adequate going forward.

 

Market risk: The company operates in a highly competitive market which is a continuing risk to the company and could result in losing revenue to its key competitors. The company manages this risk by providing value added services to its customers, responding promptly to customer requests and by maintaining strong relationships with its customers.

 

Russia and Ukraine conflict risk: The Russia Ukraine conflict has brought tragic loss of life and destruction across Ukraine. The crisis is also causing political and economic disruptions across the world, with businesses navigating conflict related risks to their people, assets, operations, and supply chains in the region and globally. The company is not reliant on supply chains within this region, so the global impact on operations is minimal. The greatest risk to the company relates to energy costs with Russia being a supplier of significant volumes of natural gas to other European countries. The effect of countries looking to purchase energy from alternative markets will increase the demand from the remaining non-Russian markets. Without a corresponding increase in supply, this is expected to increase energy prices.

 

Brexit risk: The company trades with entities based in the European Union and the exit therefrom poses a risk for the company due to the uncertainty surrounding trade agreements. This is mitigated by the loyal supplier base with which the company has traded with for a number of years. The company management is monitoring the situation and will respond to any changes that arise from Brexit.

 

On behalf of the board

Mr S Pascucci
Director
27 April 2023
AETNA (UK) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2022.

Results and dividends

The results for the year are set out on page 7.

Ordinary dividends were paid amounting to £500,000. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr S Pascucci
Mr M Dicken
Future developments

The director expects growth in the present level of turnover and profit for the foreseeable future.

Auditor

The auditor, RDP Newmans LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Strategic report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Acquisition of OCME UK Limited

On 1 January 2021 all trade and assets of OCME UK Limited were acquired by Aetna (UK) Limited. OCME UK Limited was a fellow group member of Aetna Group Holding Spa.

On behalf of the board
Mr S Pascucci
Director
27 April 2023
AETNA (UK) LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 3 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

AETNA (UK) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF AETNA (UK) LIMITED
- 4 -
Opinion

We have audited the financial statements of Aetna (UK) Limited (the 'company') for the year ended 31 December 2022 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including section FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 December 2022 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

AETNA (UK) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF AETNA (UK) LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

  • the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

  • we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the sector;

  • we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation and data protection, anti-bribery and employment;

  • we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and

  • identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

  • making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

  • considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

AETNA (UK) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF AETNA (UK) LIMITED
- 6 -

To address the risk of fraud through management bias and override of controls, we:

  • performed analytical procedures to identify any unusual or unexpected relationships;

  • reviewed and tested journal entries to identify unusual transactions and other adjustments for appropriateness, and evaluating the business rationale of significant transactions outside the normal course of business;

  • assessed whether judgements and assumptions made in determining the accounting estimates set out in note 2 were indicative of potential bias; and

  • investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

  • reviewing and agreeing financial statement disclosures and testing to underlying supporting documentation;

  • enquiring of management as to actual and potential litigation and claims; and

  • reviewing correspondence with HMRC and bankers.

No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity’s controls, and the nature, timing and extent of the audit procedures performed. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.

Paresh Radia FCA
Senior Statutory Auditor
For and on behalf of RDP Newmans LLP
9 May 2023
Chartered Accountants
Statutory Auditor
Lynwood House
373-375 Station Road
Harrow
Middlesex
HA1 2AW
AETNA (UK) LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2022
- 7 -
2022
2021
Notes
£
£
Turnover
3
14,538,180
15,423,530
Cost of sales
(9,477,887)
(10,307,422)
Gross profit
5,060,293
5,116,108
Distribution costs
(459,928)
(410,460)
Administrative expenses
(3,835,528)
(3,753,231)
Operating profit
4
764,837
952,417
Interest receivable and similar income
7
4,071
-
0
Interest payable and similar expenses
8
(34)
-
0
Profit before taxation
768,874
952,417
Tax on profit
9
(149,122)
(197,533)
Profit for the financial year
619,752
754,884

The profit and loss account has been prepared on the basis that all operations are continuing operations.

AETNA (UK) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2022
31 December 2022
- 8 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
11
365,890
359,307
Current assets
Stocks
12
638,582
855,013
Debtors
13
5,081,003
4,187,889
Cash at bank and in hand
1,031,416
262,580
6,751,001
5,305,482
Creditors: amounts falling due within one year
14
(5,217,834)
(3,980,901)
Net current assets
1,533,167
1,324,581
Total assets less current liabilities
1,899,057
1,683,888
Provisions for liabilities
Provisions
15
196,335
101,016
Deferred tax liability
16
5,270
5,172
(201,605)
(106,188)
Net assets
1,697,452
1,577,700
Capital and reserves
Called up share capital
18
100,000
100,000
Profit and loss reserves
1,597,452
1,477,700
Total equity
1,697,452
1,577,700
The financial statements were approved by the board of directors and authorised for issue on 27 April 2023 and are signed on its behalf by:
Mr S Pascucci
Director
Company Registration No. 02522111
AETNA (UK) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022
- 9 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2021
100,000
1,022,816
1,122,816
Year ended 31 December 2021:
Profit and total comprehensive income for the year
-
754,884
754,884
Dividends
10
-
(300,000)
(300,000)
Balance at 31 December 2021
100,000
1,477,700
1,577,700
Year ended 31 December 2022:
Profit and total comprehensive income for the year
-
619,752
619,752
Dividends
10
-
(500,000)
(500,000)
Balance at 31 December 2022
100,000
1,597,452
1,697,452
AETNA (UK) LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 10 -
2022
2021
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
23
1,551,463
22,178
Interest paid
(34)
-
0
Income taxes paid
(252,476)
(71,832)
Net cash inflow/(outflow) from operating activities
1,298,953
(49,654)
Investing activities
Purchase of tangible fixed assets
(34,188)
(365,085)
Proceeds from disposal of tangible fixed assets
-
0
(370)
Interest received
4,071
-
0
Net cash used in investing activities
(30,117)
(365,455)
Financing activities
Dividends paid
(500,000)
(300,000)
Net cash used in financing activities
(500,000)
(300,000)
Net increase/(decrease) in cash and cash equivalents
768,836
(715,109)
Cash and cash equivalents at beginning of year
262,580
977,689
Cash and cash equivalents at end of year
1,031,416
262,580
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 11 -
1
Accounting policies
Company information

Aetna (UK) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Packaging Heights, Highfield Parc Highfield Road, Oakley, Bedfordshire, MK43 7TA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that thetrue

company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line
Leasehold improvements
over the term of the lease of 15 years
Plant and equipment
20% straight line and 10% straight line
Fixtures and fittings
22.5% reducing balance, 22.5% straight line and 50% straight line
Computers
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 12 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 13 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 14 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 15 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Coronavirus pandemic

The directors have assessed the impact of the Coronavirus pandemic on the company and are of the opinion that this should not materially impact the company in the long term.

3
Turnover and other revenue
2022
2021
£
£
Turnover analysed by class of business
Sale of goods
14,538,180
15,423,530
2022
2021
£
£
Turnover analysed by geographical market
UK
14,538,180
15,423,530
2022
2021
£
£
Other revenue
Interest income
4,071
-
4
Operating profit
2022
2021
Operating profit for the year is stated after charging:
£
£
Exchange losses
2,171
4,181
Fees payable to the company's auditor for the audit of the company's financial statements
25,500
14,500
Depreciation of owned tangible fixed assets
27,605
31,108
(Profit)/loss on disposal of tangible fixed assets
-
0
370
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 16 -
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total employees
48
45

Their aggregate remuneration comprised:

2022
2021
£
£
Wages and salaries
2,224,377
2,188,211
Social security costs
254,852
243,002
Pension costs
170,483
147,444
2,649,712
2,578,657
6
Directors' remuneration
2022
2021
£
£
Remuneration for qualifying services
200,106
183,849
Remuneration disclosed above include the following amounts paid to the highest paid director:
2022
2021
£
£
Remuneration for qualifying services
200,106
183,849
7
Interest receivable and similar income
2022
2021
£
£
Interest income
Interest on bank deposits
4,071
-
0
8
Interest payable and similar expenses
2022
2021
£
£
Other interest
34
-
0
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 17 -
9
Taxation
2022
2021
£
£
Current tax
UK corporation tax on profits for the current period
149,024
197,533
Deferred tax
Origination and reversal of timing differences
98
-
0
Total tax charge
149,122
197,533

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2022
2021
£
£
Profit before taxation
768,874
952,417
Expected tax charge based on the standard rate of corporation tax in the UK of 19.00% (2021: 19.00%)
146,086
180,959
Tax effect of expenses that are not deductible in determining taxable profit
3,637
9,563
Permanent capital allowances in excess of depreciation
(2,233)
3,429
Timing differences
503
301
Other
1,031
3,281
Deferred tax adjustment
98
-
0
Taxation charge for the year
149,122
197,533
10
Dividends
2022
2021
£
£
Interim paid
500,000
300,000
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 18 -
11
Tangible fixed assets
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
£
Cost
At 1 January 2022
340,000
97,928
27,865
164,867
10,162
640,822
Additions
-
0
-
0
23,495
10,693
-
0
34,188
At 31 December 2022
340,000
97,928
51,360
175,560
10,162
675,010
Depreciation and impairment
At 1 January 2022
6,800
97,928
25,017
149,754
2,016
281,515
Depreciation charged in the year
6,800
-
0
3,137
15,218
2,450
27,605
At 31 December 2022
13,600
97,928
28,154
164,972
4,466
309,120
Carrying amount
At 31 December 2022
326,400
-
0
23,206
10,588
5,696
365,890
At 31 December 2021
333,200
-
0
2,848
15,113
8,146
359,307
12
Stocks
2022
2021
£
£
Finished goods and goods for resale
638,582
855,013
13
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
3,923,709
3,895,336
Prepayments and accrued income
1,157,294
292,553
5,081,003
4,187,889
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 19 -
14
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
532,689
398,537
Amounts owed to group undertakings
2,164,503
1,882,726
Corporation tax
49,532
152,984
Other taxation and social security
634,367
406,423
Other creditors
-
0
340,000
Accruals and deferred income
1,836,743
800,231
5,217,834
3,980,901
15
Provisions for liabilities
2022
2021
£
£
Warranty provision
196,335
101,016
Movements on provisions:
Warranty provision
£
At 1 January 2022
101,016
Additional provisions in the year
95,319
At 31 December 2022
196,335

Warranty provisions are estimated based on expected warranty costs on sales made by the company. The company generally operates a two year warranty period.

16
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2022
2021
Balances:
£
£
Accelerated capital allowances
5,270
5,172
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
16
Deferred taxation
(Continued)
- 20 -
2022
Movements in the year:
£
Liability at 1 January 2022
5,172
Charge to profit or loss
98
Liability at 31 December 2022
5,270
17
Retirement benefit schemes
2022
2021
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
170,483
147,444

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

18
Share capital
2022
2021
2022
2021
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
70,000
70,000
70,000
70,000
Ordinary B shares of £1 each
30,000
30,000
30,000
30,000
100,000
100,000
100,000
100,000

The Ordinary A and B shares constitute different classes of shares for the purposes of the Companies Act 2006. The Ordinary A shares and B shares rank pari passu in all respects except that the directors are empowered to declare dividends to any one or more of the share categories separately.

19
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2022
2021
£
£
Within one year
205,036
173,533
Between two and five years
323,878
338,609
528,914
512,142
AETNA (UK) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 21 -
20
Related party transactions
Transactions with related parties

The company has taken advantage of the exemption to subsidiary undertakings not to disclose transactions and balances with other group companies as the parent undertaking prepares consolidated accounts. The company is a wholly owned subsidiary of the parent undertaking.

21
Ultimate controlling party

The company's ultimate parent undertaking is Aetna Group Holding Spa. Consolidated accounts for the group of Aetna Group Holding Spa can be obtained from the following address:

 

Aetna Group Holding Spa,

S P Marechchia, 59,

47826 Villa Verucchio (RN)

Italy

22
Coronavirus pandemic

The impact of the Coronavirus outbreak has continued to materially and adversely affect businesses worldwide. The UK Government announced various lockdowns due to the pandemic. These have since been lifted. Similarly, governments across the world have imposed various restrictions to deal with the pandemic. In the opinion of the directors, there has been no significant impact on the company's activities.

23
Cash generated from operations
2022
2021
£
£
Profit for the year after tax
619,752
754,884
Adjustments for:
Taxation charged
149,122
197,533
Finance costs
34
-
0
Investment income
(4,071)
-
0
(Gain)/loss on disposal of tangible fixed assets
-
0
370
Depreciation and impairment of tangible fixed assets
27,605
31,108
Increase in provisions
95,319
511
Movements in working capital:
Decrease/(increase) in stocks
216,431
(121,572)
Increase in debtors
(893,114)
(1,068,133)
Increase in creditors
1,340,385
227,477
Cash generated from operations
1,551,463
22,178
24
Analysis of changes in net funds
1 January 2022
Cash flows
31 December 2022
£
£
£
Cash at bank and in hand
262,580
768,836
1,031,416
2022-12-312022-01-01falseCCH SoftwareCCH Accounts Production 2023.100No description of principal activityMr S PascucciMr M Dicken025221112022-01-012022-12-3102522111bus:Director12022-01-012022-12-3102522111bus:Director22022-01-012022-12-3102522111bus:RegisteredOffice2022-01-012022-12-31025221112022-12-31025221112021-01-012021-12-3102522111core:RetainedEarningsAccumulatedLosses2021-01-012021-12-3102522111core:RetainedEarningsAccumulatedLosses2022-01-012022-12-31025221112021-12-3102522111core:LandBuildingscore:OwnedOrFreeholdAssets2022-12-3102522111core:LeaseholdImprovements2022-12-3102522111core:PlantMachinery2022-12-3102522111core:FurnitureFittings2022-12-3102522111core:ComputerEquipment2022-12-3102522111core:LandBuildingscore:OwnedOrFreeholdAssets2021-12-3102522111core:LeaseholdImprovements2021-12-3102522111core:PlantMachinery2021-12-3102522111core:FurnitureFittings2021-12-3102522111core:ComputerEquipment2021-12-3102522111core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3102522111core:CurrentFinancialInstrumentscore:WithinOneYear2021-12-3102522111core:CurrentFinancialInstruments2022-12-3102522111core:CurrentFinancialInstruments2021-12-3102522111core:ShareCapital2022-12-3102522111core:ShareCapital2021-12-3102522111core:RetainedEarningsAccumulatedLosses2022-12-3102522111core:RetainedEarningsAccumulatedLosses2021-12-3102522111core:ShareCapital2020-12-3102522111core:RetainedEarningsAccumulatedLosses2020-12-3102522111core:ShareCapitalOrdinaryShares2022-12-3102522111core:ShareCapitalOrdinaryShares2021-12-31025221112021-12-31025221112020-12-3102522111core:LandBuildingscore:OwnedOrFreeholdAssets2022-01-012022-12-3102522111core:LeaseholdImprovements2022-01-012022-12-3102522111core:PlantMachinery2022-01-012022-12-3102522111core:FurnitureFittings2022-01-012022-12-3102522111core:ComputerEquipment2022-01-012022-12-310252211112022-01-012022-12-310252211112021-01-012021-12-3102522111core:UKTax2022-01-012022-12-3102522111core:UKTax2021-01-012021-12-310252211122022-01-012022-12-310252211122021-01-012021-12-310252211132022-01-012022-12-310252211132021-01-012021-12-3102522111core:LandBuildingscore:OwnedOrFreeholdAssets2021-12-3102522111core:LeaseholdImprovements2021-12-3102522111core:PlantMachinery2021-12-3102522111core:FurnitureFittings2021-12-3102522111core:ComputerEquipment2021-12-3102522111core:WithinOneYear2022-12-3102522111core:WithinOneYear2021-12-3102522111core:BetweenTwoFiveYears2022-12-3102522111core:BetweenTwoFiveYears2021-12-3102522111bus:PrivateLimitedCompanyLtd2022-01-012022-12-3102522111bus:FRS1022022-01-012022-12-3102522111bus:Audited2022-01-012022-12-3102522111bus:FullAccounts2022-01-012022-12-31xbrli:purexbrli:sharesiso4217:GBP